Thermo Fisher Scientific will pay $450 million in cash for Mesa Biotech, which launched one of the first rapid Covid-19 tests in the early days of the pandemic.
Thermo Fisher To Buy Covid-19 Test Maker Mesa Biotech For $450 Million
Thermo Fisher Scientific will pay $450 million in cash for Mesa Biotech, which launched one of the first rapid Covid-19 tests in the early days of the pandemic.